For instance, using a PDX mouse model, Bernat-Peguera A et al [80] revealed that cutaneous squamous cell carcinoma (CSCC) tumors harboring the PIK3CA-E545K mutation were resistant to gefitinib, an inhibitor of EGFR. The gene discussed is PIK3CA; the disease is skin squamous cell carcinoma.